Scisparc Ltd (SPRC)

$0.28

+0.05

(+22.27%)

Live

Performance

  • $0.23
    $0.28
    $0.28
    downward going graph

    17.86%

    Downside

    Day's Volatility :17.86%

    Upside

    0.0%

    downward going graph
  • $0.21
    $14.22
    $0.28
    downward going graph

    26.61%

    Downside

    52 Weeks Volatility :98.55%

    Upside

    98.03%

    downward going graph

Returns

PeriodScisparc LtdIndex (Russel 2000)
3 Months
-65.94%
0.0%
6 Months
-81.21%
0.0%
1 Year
-95.86%
0.0%
3 Years
-99.87%
-23.0%

Highlights

Market Capitalization
2.4M
Book Value
$10.77
Earnings Per Share (EPS)
-14.43
Profit Margin
-177.91%
Operating Margin TTM
-309.37%
Return On Assets TTM
-33.12%
Return On Equity TTM
-73.37%
Revenue TTM
2.9M
Revenue Per Share TTM
7.06
Quarterly Revenue Growth YOY
-32.7%
Gross Profit TTM
1.0M
EBITDA
-5.3M
Diluted Eps TTM
-14.43
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Company Financials

FY18Y/Y Change
Revenue
838.0K
↑ 72.07%
Net Income
-8.5M
↑ 36.5%
Net Profit Margin
-1.0K%
↑ 265.08%
FY19Y/Y Change
Revenue
498.0K
↓ 40.57%
Net Income
-5.4M
↓ 37.09%
Net Profit Margin
-1.1K%
↓ 59.65%
FY20Y/Y Change
Revenue
550.0K
↑ 10.44%
Net Income
-3.5M
↓ 34.6%
Net Profit Margin
-637.64%
↑ 439.07%
FY21Y/Y Change
Revenue
1.1M
↑ 94.36%
Net Income
-5.8M
↑ 65.41%
Net Profit Margin
-542.66%
↑ 94.98%
FY22Y/Y Change
Revenue
1.3M
↑ 26.01%
Net Income
-2.6M
↓ 55.32%
Net Profit Margin
-192.43%
↑ 350.23%
FY23Y/Y Change
Revenue
2.9M
↑ 113.73%
Net Income
-5.1M
↑ 97.61%
Net Profit Margin
-177.91%
↑ 14.52%
Q1 FY23Q/Q Change
Revenue
1.3M
-
Net Income
3.2M
-
Net Profit Margin
235.12%
-
Q2 FY23Q/Q Change
Revenue
2.0M
↑ 46.4%
Net Income
-2.9M
↓ 190.94%
Net Profit Margin
-146.04%
↓ 381.16%
Q1 FY24Q/Q Change
Revenue
907.0K
↓ 54.01%
Net Income
-2.2M
↓ 22.15%
Net Profit Margin
-247.19%
↓ 101.15%
FY18Y/Y Change
Total Assets
4.6M
↓ 52.33%
Total Liabilities
4.5M
↑ 280.88%
FY19Y/Y Change
Total Assets
1.2M
↓ 74.69%
Total Liabilities
1.1M
↓ 74.57%
FY20Y/Y Change
Total Assets
2.6M
↑ 121.92%
Total Liabilities
1.1M
↓ 0.79%
FY21Y/Y Change
Total Assets
9.9M
↑ 287.19%
Total Liabilities
1.8M
↑ 56.94%
FY22Y/Y Change
Total Assets
10.6M
↑ 6.95%
Total Liabilities
4.2M
↑ 134.14%
FY23Y/Y Change
Total Assets
11.2M
↑ 5.44%
Total Liabilities
1.6M
↓ 61.62%
Q3 FY22Q/Q Change
Total Assets
22.5M
↑ 55.69%
Total Liabilities
14.1M
↑ 23.89%
Q4 FY22Q/Q Change
Total Assets
10.6M
↓ 52.77%
Total Liabilities
4.2M
↓ 70.54%
Q1 FY23Q/Q Change
Total Assets
10.6M
↑ 0.0%
Total Liabilities
4.2M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
9.9M
↓ 6.72%
Total Liabilities
3.1M
↓ 25.07%
Q4 FY23Q/Q Change
Total Assets
11.2M
↑ 13.04%
Total Liabilities
1.6M
↓ 48.78%
Q1 FY24Q/Q Change
Total Assets
11.2M
↑ 0.0%
Total Liabilities
1.6M
↑ 0.0%
FY18Y/Y Change
Operating Cash Flow
-7.1M
↑ 55.75%
Investing Cash Flow
-2.1M
↑ 3850.94%
Financing Cash Flow
1.5M
↓ 88.34%
FY19Y/Y Change
Operating Cash Flow
-4.7M
↓ 34.16%
Investing Cash Flow
1.3M
↓ 160.55%
Financing Cash Flow
2.8M
↑ 82.55%
FY20Y/Y Change
Operating Cash Flow
-4.3M
↓ 8.28%
Investing Cash Flow
24.0K
↓ 98.11%
Financing Cash Flow
5.4M
↑ 91.12%
FY21Y/Y Change
Operating Cash Flow
-5.1M
↑ 17.51%
Investing Cash Flow
-70.0K
↓ 391.67%
Financing Cash Flow
10.1M
↑ 87.72%
FY22Y/Y Change
Operating Cash Flow
-7.9M
↑ 56.43%
Investing Cash Flow
-7.1M
↑ 10020.0%
Financing Cash Flow
11.7M
↑ 16.3%
Q3 FY22Q/Q Change
Operating Cash Flow
-2.9M
↑ 30.92%
Investing Cash Flow
-3.2M
-
Financing Cash Flow
1.4M
↓ 84.75%
Q4 FY22Q/Q Change
Operating Cash Flow
-2.9M
↑ 0.0%
Investing Cash Flow
-3.2M
↑ 0.0%
Financing Cash Flow
1.4M
↑ 0.0%
Q1 FY23Q/Q Change
Operating Cash Flow
-5.7M
↑ 100.0%
Investing Cash Flow
-535.5K
↓ 83.2%
Financing Cash Flow
2.7M
↑ 100.0%
Q2 FY23Q/Q Change
Operating Cash Flow
-3.2M
↓ 43.57%
Investing Cash Flow
-535.5K
↑ 0.0%
Financing Cash Flow
2.8M
↑ 2.82%

Technicals Summary

Sell

Neutral

Buy

Scisparc Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Scisparc Ltd
Scisparc Ltd
-13.18%
-81.21%
-95.86%
-99.87%
-99.87%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-9.28%
10.06%
24.53%
74.0%
232.45%
Novo Nordisk A/s
Novo Nordisk A/s
-4.54%
-5.72%
21.59%
126.2%
349.01%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
8.87%
102.98%
82.67%
44.83%
241.09%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
5.0%
20.77%
31.37%
158.16%
163.17%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Scisparc Ltd
Scisparc Ltd
0.0
NA
NA
0.0
-0.73
-0.33
NA
10.77
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
26.41
26.41
1.37
44.9
0.17
0.08
NA
261.41
Novo Nordisk A/s
Novo Nordisk A/s
40.21
40.21
1.81
3.36
0.89
0.23
0.01
25.24
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-2.42
-15.01
0.02
NA
-0.02
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
0.59
0.18
-0.03
0.13
NA
57.26
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Scisparc Ltd
Scisparc Ltd
NA
$2.4M
-99.87%
0.0
-177.91%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$110.0B
232.45%
26.41
32.04%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$529.8B
349.01%
40.21
34.84%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$38.1B
241.09%
NA
-3.11%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$128.7B
163.17%
32.84
-4.74%

Insights on Scisparc Ltd

  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 82.9% return, outperforming this stock by 178.5%

Institutional Holdings

  • Renaissance Technologies Corp

    0.38%
  • Citadel Advisors Llc

    0.23%
  • Two Sigma Investments LLC

    0.12%
  • Rhumbline Advisers

    0.03%
  • UBS Group AG

    0.03%

Company Information

Organization
Scisparc Ltd
Employees
3
CEO
Mr. Oz Adler CPA
Industry
Miscellaneous

FAQs